Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 82
Filtrar
1.
Toxicon ; 152: 30-36, 2018 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-29981815

RESUMO

Hemiscorpius lepturus (H. lepturus) is one of the most dangerous scorpions and the most medically important scorpion in Iran. The clinical signs of H. lepturus envenomation, including dermonecrosis, hematuria, renal failure and early death, are attributed to phospholipase D activity. This study was conducted to develop a novel recombinant phospholipase D1 (rPLD1) toxoid and investigate its immunogenicity and protective effects against the lethality of H. lepturus venom. The lethal protein recombinant phospholipase D1 was expressed from PLD H. lepturus venom gland. The rPLD1 toxin was converted into toxoid (the first toxoid of H. lepturus PLD) with a 0.25% concentration of formalin and stored for ten days at room temperature. In the toxicity test, the lethal activity of recombinant phospholipase D1 was fully inhibited. When it reached up to 3 times higher than the maximal effective concentration of the purified toxin (11.1 µg), rPLD1 toxoid was used. The sphingomyelinase activity was inhibited when up to 5.4 times of the LD100 of the purified toxin (20 µg), toxoid was used. It was then used to produce an antibody in BALB/c as an antigen and the mice were then challenged with rPLD1 toxin and the whole venom. The immunogenicity of rPLD1 toxoid was evaluated and the maximum titer of the raised antibodies was determined by ELISA assay. The optimum titer for anti-rPLD1 toxoid sera was obtained at the third intraperitoneal injection of rPLD1 toxoid, and a high titer was reached at the fourth injection in the mice. This toxoid increased the amount of antibodies and produced a protective antiserum against the whole venom of H. lepturus and rPLD1 toxin. The in-vivo test results showed that the mice were completely resistant against 200 times the LD100 of recombinant phospholipase D1 and the whole venom of H. lepturus. To conclude, rPLD1 can be used in toxoid form as an immunogen in the production of a new generation of neutralizing antibodies against the lethality and toxicity of H. lepturus whole venom.


Assuntos
Fosfolipase D/imunologia , Venenos de Escorpião/enzimologia , Toxoides/imunologia , Animais , Anticorpos Neutralizantes , Escherichia coli/imunologia , Formaldeído , Irã (Geográfico) , Camundongos Endogâmicos BALB C , Fosfolipase D/genética , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/isolamento & purificação , Venenos de Escorpião/imunologia , Escorpiões , Esfingomielina Fosfodiesterase , Toxoides/isolamento & purificação
2.
Jpn J Infect Dis ; 70(4): 423-429, 2017 Jul 24.
Artigo em Inglês | MEDLINE | ID: mdl-28250257

RESUMO

Botulinum toxin is the most poisonous substance known, and is believed to be a highly lethal as a biological weapon; researchers of the toxin are exposed to this hazard. Botulinum toxoid vaccines have been produced and used in Japan. However, since clinical studies involving these vaccines were conducted before establishment of the Ethical Guidelines for Clinical Research in Japan, their immunogenicity and safety were not systematically assessed. In this study, we produced a new tetravalent (type A, B, E, and F) botulinum toxoid vaccine, the first ever to be derived from M toxin, and conducted quality control tests with reference to the Minimum Requirements in Japan for adsorbed tetanus toxoid vaccine. Subsequently, a clinical study using the new vaccine in 48 healthy adult volunteers was conducted according to the guidelines in Japan. No clinically serious adverse event was noted. Neutralizing antibody titers for each type of toxin in the participants' sera, 1 month after the 4th injection were more than 0.25 IU/mL, indicating sufficient protection. This study demonstrated that the vaccine has marked immunogenicity and is safe for use in humans.


Assuntos
Vacinas Bacterianas/imunologia , Toxinas Botulínicas/imunologia , Botulismo/prevenção & controle , Toxoides/imunologia , Adulto , Animais , Antitoxinas/sangue , Vacinas Bacterianas/administração & dosagem , Vacinas Bacterianas/efeitos adversos , Vacinas Bacterianas/isolamento & purificação , Ensaio de Imunoadsorção Enzimática , Feminino , Cobaias , Voluntários Saudáveis , Humanos , Japão , Masculino , Camundongos , Pessoa de Meia-Idade , Toxoides/administração & dosagem , Toxoides/efeitos adversos , Toxoides/isolamento & purificação , Resultado do Tratamento , Adulto Jovem
3.
Immunol Lett ; 167(1): 47-53, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26141623

RESUMO

Vibrio vulnificus hemolysin A (VvhA) is a pore forming toxin and plays an important role in the pathogenesis. The hemolytic and cytotytic property of VvhA toxin is associated with N-terminal leukocidin domain which triggers apoptotic signaling cascade in epithelial cells. The present study was undertaken to assess the protective efficacy of recombinant VvhA leukocidin domain (rL/VvhA) against VvhA toxin challenge using in vitro and in vivo assays. The rL/VvhA protein was found to be non-toxic with no significant hemolytic or cytotoxic effects. Intraperitoneal (I.P.) immunization of BALB/c mice with rL/VvhA protein elicited significantly higher specific serum antibody titer with mixed Th1/Th2 mediated immune responses. HeLa cell monolayer supplemented with anti-rL/VvhA antibodies were effectively protected (viability 86.69%) against lethal 5 LD50 toxin challenge. An effective in vitro proliferation of lymphocyte was observed upon re-stimulation of rL/VvhA primed splenocytes with formalin inactivated VvhA toxin (fVvhA). Co-expression of Th1/Th2 polarized cytokines (IFN-γ, IL-12 and IL-4), were seen in the cell culture supernatant. In contrast to sham immunized mice, rL/VvhA immunized mice demonstrated significant protection (90% survival) against native toxin challenge in vitro and in vivo infection models. These results suggested leukocidin domain of the VvhA toxin as protective immunogen for possible protection against V. vulnificus VvhA.


Assuntos
Leucocidinas/imunologia , Domínios e Motivos de Interação entre Proteínas/imunologia , Proteínas Recombinantes , Toxoides/imunologia , Vibrio vulnificus/imunologia , Animais , Anticorpos Antibacterianos/imunologia , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Proteínas de Bactérias/imunologia , Proteínas de Bactérias/isolamento & purificação , Clonagem Molecular , Citocinas/metabolismo , Feminino , Expressão Gênica , Imunização , Leucocidinas/genética , Leucocidinas/isolamento & purificação , Ativação Linfocitária/imunologia , Linfócitos/imunologia , Linfócitos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Testes de Neutralização , Domínios e Motivos de Interação entre Proteínas/genética , Baço/citologia , Baço/imunologia , Baço/metabolismo , Toxoides/genética , Toxoides/isolamento & purificação , Vibrioses/imunologia , Vibrioses/mortalidade , Vibrioses/prevenção & controle , Vibrio vulnificus/genética
4.
Microbiol Immunol ; 58(11): 621-7, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25197030

RESUMO

Cattle enterotoxemia caused by Clostridium perfringens toxins is a noncontagious, sporadic, and fatal disease characterized by sudden death. Strategies for controlling and preventing cattle enterotoxemia are based on systematic vaccination of herds with toxoids. Because the process of producing conventional clostridial vaccines is dangerous, expensive, and time-consuming, the prospect of recombinant toxoid vaccines against diseases caused by C. perfringens toxins is promising. In this study, nontoxic recombinant toxoids derived from α-, ß- and ε-toxins of C. perfringens, namely, rCPA247-370 , rCPB and rEtxHP, respectively, were expressed in Escherichia coli. High levels of specific IgG antibodies and neutralizing antibodies against the toxins were detected in sera from calves vaccinated with either a single recombinant toxoid or a mixed cocktail of all three recombinant toxoids, indicating the potential of these recombinant toxoids to provide calves with protective immunity against enterotoxemia caused by C. perfringens.


Assuntos
Doenças dos Bovinos/prevenção & controle , Infecções por Clostridium/veterinária , Clostridium perfringens/imunologia , Enterotoxemia/prevenção & controle , Toxoides/administração & dosagem , Toxoides/imunologia , Animais , Anticorpos Antibacterianos/sangue , Anticorpos Neutralizantes/sangue , Antitoxinas/sangue , Bovinos , Infecções por Clostridium/prevenção & controle , Clostridium perfringens/genética , Escherichia coli/genética , Feminino , Expressão Gênica , Imunoglobulina G/sangue , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/isolamento & purificação , Toxoides/genética , Toxoides/isolamento & purificação
5.
Anal Biochem ; 437(1): 40-2, 2013 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-23499969

RESUMO

The overall structure of pertussis toxoid has been established by analysis of its tryptic digest using two-dimensional liquid chromatography-tandem mass spectrometry (2D-LC-MS/MS), capillary liquid chromatography-matrix-assisted laser desorption ionization-tandem mass spectrometry (CapLC-MALDI-MS/MS), and ultraperformance liquid chromatography-mass spectrometry(E) (UPLC-MS(E)). In addition to oxidation and hydrolysis of amino acids losses of terminal peptides are observed. On-line UPLC-MS(E) generated a similar sequence coverage as the other two methods that involved off-line fraction collection. In light of recent favorable comparisons to data-dependent acquisition, UPLC-MS(E) should be the initial method of choice for analysis of a peptide mixture of moderate complexity.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Espectrometria de Massas em Tandem/métodos , Toxoides/química , Sequência de Aminoácidos , Dados de Sequência Molecular , Toxoides/isolamento & purificação
6.
Microbiol Immunol ; 57(1): 38-45, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23157558

RESUMO

Enterohemorrhagic Escherichia coli (EHEC) causes hemorrhagic colitis, and in more severe cases, a serious clinical complication called hemolytic uremic syndrome (HUS). Shiga toxin (Stx)is one of the factors that cause HUS. Serotypes of Stx produced by EHEC include Stx1 and Stx2. Although some genetically mutated toxoids of Stx have been developed, large-scale preparation of Stx that is practical for vaccine development has not been reported. Therefore, overexpression methods for Stx2 and mutant Stx2 (mStx2) in E. coli were developed. The expression plasmid pBSK-Stx2(His) was constructed by inserting the full-length Stx2 gene, in which a six-histidine tag gene was fused at the end of the B subunit into the lacZα fragment gene of the pBluescript II SK(+) vector. An E. coli MV1184 strain transformed with pBSK-Stx2(His) overexpressed histidine-tagged Stx2 (Stx2-His) in cells cultured in CAYE broth in the presence of lincomycin. Stx2-His was purified using TALON metal affinity resin followed by hydroxyapatite chromatography. From 1 L of culture, 68.8 mg of Stx2-His and 61.1 mg of mStx2-His, which was generated by site-directed mutagenesis, were obtained. Stx2-His had a cytotoxic effect on HeLa cells and was lethal to mice. However, the toxicity of mStx2-His was approximately 1000-fold lower than that of Stx2-His. Mice immunized with mStx2-His produced specific antibodies that neutralized the toxicity of Stx2 in HeLa cells. Moreover, these mice survived challenge with high doses of Stx2-His. Therefore, the lincomycin-inducible overexpression method is suitable for large-scale preparation of Stx2 vaccine antigens.


Assuntos
Vacinas Bacterianas/isolamento & purificação , Escherichia coli/genética , Toxina Shiga II/isolamento & purificação , Toxoides/isolamento & purificação , Animais , Anticorpos Antibacterianos/sangue , Anticorpos Neutralizantes/sangue , Antígenos de Bactérias/biossíntese , Antígenos de Bactérias/genética , Antígenos de Bactérias/imunologia , Antígenos de Bactérias/toxicidade , Sobrevivência Celular/efeitos dos fármacos , Cromatografia de Afinidade , Cromatografia Líquida , Feminino , Expressão Gênica , Vetores Genéticos , Células HeLa , Humanos , Camundongos , Camundongos Endogâmicos ICR , Plasmídeos , Intoxicação , Toxina Shiga II/biossíntese , Toxina Shiga II/genética , Toxina Shiga II/toxicidade , Análise de Sobrevida , Toxoides/toxicidade , Vacinas Sintéticas/isolamento & purificação
7.
Toxicon ; 50(2): 292-301, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17517427

RESUMO

In November 2005, at least five dogs died rapidly after contact with water from the Hutt River (lower North Island, New Zealand). Necropsy performed 24h later on one of the dogs (a 20-month-old Labrador) revealed few findings of interest, except for copious amounts of froth in the respiratory tract down to the bifurcation of the trachea and large quantities of algal material in the dog's stomach. Low and relatively stable flows in the Hutt River during spring had resulted in the proliferation of benthic cyanobacteria that formed large black/brown mats along the river edge. Samples from the Labrador's stomach contents and cyanobacterial mats were analysed microscopically and screened using chemical and biochemical assays for cyanotoxins: anatoxin-a, homoanatoxin-a, cylindrospermopsins, saxitoxins and microcystins. Liquid chromatography-mass spectrometry (LC-MS) confirmed the presence of the neurotoxic cyanotoxins anatoxin-a and homoanatoxin-a and their degradation products, dihydro-anatoxin-a and dihydro-homoanatoxin-a. This is the first report of homoanatoxin-a and associated degradation product in New Zealand. Based on morphology, the causative species was identified as Phormidium sp. Subsequent phylogenetic analysis of 16S rRNA gene sequences demonstrated that the causative organism was most similar to Phormidium autumnale. Further investigations led to the detection of homoanatoxin-a and anatoxin-a in cyanobacterial mats from four other rivers in the Wellington region (lower North Island, New Zealand). Access restrictions were placed on over 60% of river catchments in the western Wellington region, severely affecting recreational users.


Assuntos
Toxinas Bacterianas/intoxicação , Doenças do Cão/induzido quimicamente , Toxinas Marinhas/intoxicação , Síndromes Neurotóxicas/patologia , Síndromes Neurotóxicas/veterinária , Animais , Compostos Bicíclicos Heterocíclicos com Pontes , Clonagem Molecular , Cianobactérias/química , Cianobactérias/ultraestrutura , DNA Bacteriano/química , DNA Bacteriano/genética , DNA Ribossômico/química , DNA Ribossômico/efeitos dos fármacos , Cães , Conteúdo Gastrointestinal/química , Microcistinas/química , Microcistinas/isolamento & purificação , Microcistinas/toxicidade , Nova Zelândia , RNA Ribossômico 16S/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Saxitoxina/química , Saxitoxina/isolamento & purificação , Saxitoxina/toxicidade , Fixação de Tecidos , Toxoides/química , Toxoides/isolamento & purificação
8.
J Med Microbiol ; 51(10): 813-820, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12435059

RESUMO

Clostridium botulinum types C and D produce a 16 S (500 kDa) toxin that is formed by conjugation of neurotoxin with a non-toxic component (nonTox). The amino acid sequences of type C and D nonTox components are almost identical. In a previous report it was proposed that nonTox is necessary for the effective absorption of the toxin from the small intestine. This suggested the hypothesis that mucosal immunity against nonTox in the small intestine might prevent the absorption of both C- and D-16 S toxins. The nonTox was purified from a mutant strain, (C)-N71, that does not produce neurotoxin. This nonTox or detoxified C-16 S toxin were mixed with adjuvant (a mutant form of heat-labile toxin of Escherichia coli), and inoculated into mice via the nasal or oral route, or both. The mice inoculated nasally four times with nonTox or toxoid produced high levels of antibodies (including IgA) against the immunogens, both in intestinal fluids and sera. When these nonTox-immunised mice were challenged orally with 2 and 20 oral minimum lethal doses (MLD) of C- or D-16 S toxins, the same results were obtained with both C and D; the mice survived after challenge with 2 MLD of either C or D but were killed by 20 MLD of either toxin although the time to death was significantly longer than in the control non-immunised mice. These results indicate that the local anti-nonTox antibodies reduce absorption of both C- and D-16 S toxins from the small intestine. The C-16 S toxoid-immunised mice showed similar behaviour with type D toxin challenge, probably due to the same mechanism, but were protected against 20 MLD of C-16 S toxin.


Assuntos
Toxinas Botulínicas/imunologia , Clostridium botulinum/imunologia , Imunidade nas Mucosas , Toxoides/imunologia , Administração Intranasal , Administração Oral , Animais , Anticorpos Antibacterianos/biossíntese , Toxinas Botulínicas/toxicidade , Imunização , Intestinos/imunologia , Camundongos , Testes de Neutralização , Toxoides/administração & dosagem , Toxoides/isolamento & purificação
10.
Artigo em Russo | MEDLINE | ID: mdl-9662798

RESUMO

Ribosomes, sufficiently purified by physicochemical criteria (with the RNA/protein ratio equal to 1.6 - 1.7), were isolated from disintegrated C.perfringens cells, type A, strain BP6K, by ultracentrifugation or by fractionation with polyethylene glycol. The purified conjugates of ribosomes and C.perfringens toxoid, absorbed on aluminum hydroxide, were obtained. The ribosomal preparations had low toxicity and high protective activity: when used in a dose of 6 binding units, they protected guinea pigs and mice inoculated with 8 - 9 LD50 of C.perfringens culture.


Assuntos
Clostridium perfringens/ultraestrutura , Imunidade/fisiologia , Ribossomos/química , Toxoides/isolamento & purificação , Animais , Vacinas Bacterianas/isolamento & purificação , Fenômenos Químicos , Físico-Química , Cobaias , Camundongos , Ribossomos/imunologia
11.
Adv Exp Med Biol ; 371B: 1633-40, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7502872

RESUMO

The available options, past and present, of cholera vaccines have been summarized above. It is saddening but clear that, more than a century after the introduction of the first cholera vaccine, we still do not have available a suitable vaccine against cholera. The currently raging and expanding new epidemic of cholera in the Western hemisphere dramatically illustrates anew the need, although a new illustration is not necessary if one but considers the innumerable, but unnecessary, victims of cholera of the past which could have been prevented had a suitable vaccine been available earlier. Indeed, it should also be clear from this review that a suitable vaccine against cholera still eludes us and will for an additional period of time. Cholera, a disease of humans only, can be controlled by prevention of human to human transmission, i.e., by universal availability of appropriate sewage disposal and clean water--an expensive solution, but one which will also reduce the toll of the other diseases transmitted by the fecal-oral route. Short of this, we should not be diverted by less than a highly effective, and economical vaccine. The "bottleneck" resides in the difficulty of getting from the laboratory to the field: the essential, and most efficient, intermediate step being the testing of candidate vaccines in volunteers--laboratory animal models do not suffice. Cholera is now, especially under controlled conditions, a perfectly treatable disease. Additional volunteer centers, and studies in volunteers, are essential to the solution of the cholera problem in the near future.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Vacinas contra Cólera/isolamento & purificação , Administração Oral , Adulto , Animais , Criança , Cólera/história , Cólera/imunologia , Cólera/prevenção & controle , Toxina da Cólera/isolamento & purificação , Vacinas contra Cólera/administração & dosagem , Vacinas contra Cólera/história , História do Século XIX , História do Século XX , Humanos , Imunidade nas Mucosas , Toxoides/isolamento & purificação , Vacinas Atenuadas/administração & dosagem , Vacinas Atenuadas/isolamento & purificação , Vacinas de Produtos Inativados/administração & dosagem , Vacinas de Produtos Inativados/isolamento & purificação , Vacinas Sintéticas/administração & dosagem , Vacinas Sintéticas/isolamento & purificação , Vibrio cholerae/imunologia
12.
Rev. cuba. med. trop ; 45(1): 16-20, mayo - ago. 1993. tab
Artigo em Espanhol | CUMED | ID: cum-5566

RESUMO

Se describe una técnica para la preparación de un toxoide a partir de la fracción hemorrágica del veneno de Bothrops asper. Este método conserva un alto grado de inmunogenecidad aunque elimina los efectos letales. Ninguno de los animales vacunados con el toxoide de esta fracción presentó lesiones hemorrágicas cuando les fue inyectado el veneno de la fracción hemorrágica


Assuntos
Animais , Toxoides/isolamento & purificação , Toxoides/imunologia , Venenos de Serpentes/imunologia , Venenos de Serpentes/toxicidade , Fracionamento Químico/métodos , Intoxicação/prevenção & controle
13.
Rev. cuba. med. trop ; 45(1): 16-20, ene.-abr. 1993. tab
Artigo em Espanhol | LILACS | ID: lil-158437

RESUMO

Se describe una técnica para la preparación de un toxoide a partir de la fracción hemorrágica del veneno de Bothrops asper. Este método conserva un alto grado de inmunogenecidad aunque elimina los efectos letales. Ninguno de los animales vacunados con el toxoide de esta fracción presentó lesiones hemorrágicas cuando les fue inyectado el veneno de la fracción hemorrágica


Assuntos
Animais , Fracionamento Químico , Intoxicação/prevenção & controle , Venenos de Serpentes/imunologia , Venenos de Serpentes/toxicidade , Toxoides/imunologia , Toxoides/isolamento & purificação
14.
Braz J Med Biol Res ; 25(9): 913-7, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1342838

RESUMO

A cholera toxoid was prepared by iodinating purified cholera toxin having an activity of 25 Limit of blueing (Lb) doses/1 microgram with 0.8 mumol of iodine monochloride per mg toxin, and the residual lesion capacity was tested in mice. The blueing dose (BD) test was strongly positive for the native toxin, and completely abolished in the iodinated toxoid when tested at up to 25 times on Lb dose. The dermal microscopic lesions with intradermal doses of 1 microgram virulent toxin presented intense leucocyte infiltration, proteinaceous edema and active hyperemia, whereas none of these effects was observed with the same amount of toxoid. To determine antigenicity, two groups of mice received toxin or toxoid, 8.5 micrograms adsorbed to aluminum hydroxide, followed by a booster of 17 micrograms in saline 21 days later. Measurement of antibodies by ELISA at day 28 indicated that the toxoid was 2.5 times more antigenic than the toxin. These data show that iodination converts cholera toxin to an effective toxoid.


Assuntos
Toxina da Cólera/imunologia , Toxoides/isolamento & purificação , Animais , Anticorpos Antibacterianos/sangue , Toxina da Cólera/administração & dosagem , Relação Dose-Resposta Imunológica , Ensaio de Imunoadsorção Enzimática , Azul Evans/administração & dosagem , Feminino , Iodo , Masculino , Camundongos , Fatores de Tempo , Toxoides/administração & dosagem , Toxoides/imunologia , Vibrio cholerae/imunologia
16.
Roum Arch Microbiol Immunol ; 50(3): 209-14, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1821162

RESUMO

A new technique is described for the preparation of Bothrops venom and their different fractions toxoid. This method preserves a high degree of immunogenicity but eliminates lethal effects. All the animals vaccinated with Bothrops crude venom toxoid survived when they were injected with crude venom.


Assuntos
Venenos de Crotalídeos/isolamento & purificação , Toxoides/isolamento & purificação , Animais , Venenos de Crotalídeos/imunologia , Venenos de Crotalídeos/toxicidade , Formaldeído , Liofilização , Adjuvante de Freund , Hemorragia/induzido quimicamente , Imunização , Dose Letal Mediana , Camundongos , Peptídeo Hidrolases , Fatores de Tempo , Toxoides/imunologia , Toxoides/toxicidade
17.
Vaccine ; 9(2): 117-21, 1991 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2058258

RESUMO

An acellular pertussis vaccine which contains highly purified pertussis toxoid (PT) and filamentous haemagglutinin (FHA) has been developed. These proteins have been shown to be stable, with essentially no significant reversion of the pertussis toxoid after a new detoxification procedure. Two clinical trials using this vaccine as a booster in 45 healthy adults have been performed. Results show that the vaccine was well tolerated, causing essentially mild, transient symptoms after administration. It induced an increase in anti-PT and anti-FHA antibody titres in all vaccinees.


Assuntos
Vacina contra Coqueluche/isolamento & purificação , Adulto , Anticorpos Antibacterianos/biossíntese , Feminino , Hemaglutininas/administração & dosagem , Hemaglutininas/isolamento & purificação , Humanos , Imunização Secundária , Masculino , Pessoa de Meia-Idade , Vacina contra Coqueluche/administração & dosagem , Vacina contra Coqueluche/efeitos adversos , Toxoides/administração & dosagem , Toxoides/isolamento & purificação
18.
Infect Immun ; 58(10): 3337-47, 1990 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-2119344

RESUMO

Bordetella pertussis TOX3201 has a 12-base-pair insertion in the S1 subunit gene of pertussis toxin (PTX), which encodes for a 4-amino-acid insertion between residues 107 and 108 of the mature S1 subunit (Black et al., Science 240:656-659, 1988). This mutant strain has been shown to secrete a holotoxin analog of PTX, designated CRM3201, with reduced ADP-ribosyltransferase activity. In the present study, we evaluated the biochemical, biological, and immunoprotective activities of purified CRM3201. Assay of enzymatic activities showed that CRM3201 had 20 to 30% of the ADP-ribosyltransferase activity and 55 to 60% of the NAD glycohydrolase activity of native PTX. CRM3201, however, had only 2 to 6% of the activity of PTX in clustering CHO cells, promoting leukocytosis, inducing histamine sensitization, and potentiating an anaphylactic response to bovine serum albumin. In contrast, activities associated with the B oligomer (binding to fetuin, hemagglutination of goose erythrocytes, and lymphocyte mitogen activity) were comparable to those of native PTX. Injection of BALB/c mice with CRM3201 mixed with Al(OH)3 elicited high titers of antibody to PTX (as measured by enzyme-linked immunosorbent assay), which neutralized a leukocytosis-promoting dose of PTX in these mice and neutralized PTX in a CHO cell assay. Passive transfer of the anti-CRM3201 antibody protected 20-day-old Swiss-Webster mice against a lethal aerosol challenge with B. pertussis 18323. Active immunization with CRM3201 significantly reduced lung colonization in adult BALB/c mice with a B. pertussis respiratory infection. These results demonstrate (i) that the reduced ADP-ribosyltransferase activity of CRM3201 is associated with reductions in certain biological and toxic activities of PTX (the enzymatic and biological activities are not, however, totally concordant); (ii) that CRM3201 possesses a functional B oligomer; and (iii) that CRM3201 can induce toxin-neutralizing antibodies which protect mice against a respiratory challenge with B. pertussis. Our studies with CRM3201 show that recombinant analogs of PTX have the potential to be developed into safe, protective immunogens for use in new acellular pertussis vaccines.


Assuntos
Infecções por Bordetella/prevenção & controle , Toxoides/imunologia , Anafilaxia/etiologia , Animais , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/isolamento & purificação , Vacinas Bacterianas/metabolismo , Bordetella pertussis/imunologia , Células Cultivadas , Distribuição de Qui-Quadrado , Contagem de Colônia Microbiana , Ensaio de Imunoadsorção Enzimática , Testes de Hemaglutinação , Histamina/administração & dosagem , Hipersensibilidade Imediata/induzido quimicamente , Imunização , Imunização Passiva , Contagem de Leucócitos , Camundongos , Camundongos Endogâmicos BALB C , Mitógenos , Oxigenases de Função Mista/metabolismo , Testes de Neutralização , Poli(ADP-Ribose) Polimerases/metabolismo , Toxoides/isolamento & purificação , Toxoides/metabolismo
19.
J Biochem ; 107(5): 769-75, 1990 May.
Artigo em Inglês | MEDLINE | ID: mdl-2118901

RESUMO

Botulinum C1 neurotoxin and C3 exoenzyme were purified to apparent homogeneity from the culture filtrate of Clostridium botulinum type C strain 003-9. Both preparations catalyzed ADP-ribosylation of the same substrate, the Mr 22,000 rho gene product (Gb). When the light and heavy chains of C1 toxin were separated, ADP-ribosyltransferase activity in the toxin was quantitatively recovered in the light chain fraction. Anti-C1 toxin antiserum precipitated the ADP-ribosyltransferase activity and the neurotoxicity of C1 toxin in parallel, whereas it had no effect on C3 exoenzyme. On the other hand, anti-C3 exoenzyme antiserum precipitated the ADP-ribosyltransferase activities of both C3 exoenzyme and C1 toxin. This antibody, however, did not precipitate the neurotoxicity of C1 toxin. The ADP-ribosyltransferase in C1 toxin was quantitatively adsorbed onto the anti-C3 antibody column and separated from the majority of C1 toxin protein. The enzyme was then eluted with acidic urea and Western blotting analysis of this eluate revealed the appearance of a protein band positively stained with anti-C3 antibody at a position similar to that of C3 exoenzyme. Quantitative determination by enzyme-linked immunosorbent assay showed that the C3-like immunoreactivity is present in the C1 toxin molecules at the molecular ratio of 1 to 1,000. These results suggest that the ADP-ribosyltransferase activity in C1 toxin is expressed by a C3-like molecule which is present in a small amount in the toxin preparation and appears to bind to the toxin component(s). The above results also indicate that the ADP-ribosyltransferase in C1 toxin is not related to its neurotoxin action.


Assuntos
Toxinas Botulínicas/isolamento & purificação , Clostridium botulinum/análise , Poli(ADP-Ribose) Polimerases/metabolismo , Toxoides/isolamento & purificação , Anticorpos Antibacterianos/imunologia , Clostridium botulinum/enzimologia , Imunoglobulina G/imunologia , Poli(ADP-Ribose) Polimerases/imunologia , Testes de Precipitina
20.
Artigo em Russo | MEDLINE | ID: mdl-2508376

RESUMO

The protective properties of formulated toxoid obtained from the highly purified preparation of P. aeruginosa exotoxin A have been studied in the test of the active immunization of mice. The study has revealed that the preparation when introduced in 1 or 2 injections in a dose of 15 micrograms, shows faint protective potency with respect to P. aeruginosa strains differing in virulence. Immunization with this toxoid in 3 and 4 injections has been found to ensure 60-100% and 50-60% protection of mice infected with P. aeruginosa toxigenic and proteolytic strains respectively. Immunization with toxoid has been found to induce the appearance of short-term antibacterial immunity which loses its capacity to protect the immunized animals, challenged with both toxigenic and proteolytic P. aeruginosa strains, as early as on day 28. The immunization of mice with toxoid in 4 injections has been shown to induce the development of antitoxic immunity capable of neutralizing up to 150 LD50 of purified exotoxin A.


Assuntos
ADP Ribose Transferases , Toxinas Bacterianas , Exotoxinas/imunologia , Pseudomonas aeruginosa/imunologia , Toxoides/imunologia , Fatores de Virulência , Animais , Exotoxinas/isolamento & purificação , Imunização , Camundongos , Toxoides/isolamento & purificação , Exotoxina A de Pseudomonas aeruginosa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...